IQVIA Holdings Inc. (IQV)
NYSE: IQV · IEX Real-Time Price · USD
234.88
+0.90 (0.38%)
Apr 26, 2024, 4:00 PM EDT - Market closed
IQVIA Holdings Revenue
In the year 2023, IQVIA Holdings had annual revenue of $14.98B with 3.98% growth. Revenue in the quarter ending December 31, 2023 was $3.87B with 3.45% year-over-year growth.
Revenue (ttm)
$14.98B
Revenue Growth
+3.98%
P/S Ratio
2.85
Revenue / Employee
$172,230
Employees
87,000
Market Cap
42.75B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
Dec 31, 2018 | 10.41B | 710.00M | 7.32% |
Dec 31, 2017 | 9.70B | 2.89B | 42.36% |
Dec 31, 2016 | 6.82B | 1.08B | 18.79% |
Dec 31, 2015 | 5.74B | 277.00M | 5.07% |
Dec 31, 2014 | 5.46B | 360.46M | 7.07% |
Dec 31, 2013 | 5.10B | 234.03M | 4.81% |
Dec 31, 2012 | 4.87B | 537.77M | 12.43% |
Dec 31, 2011 | 4.33B | 403.73M | 10.29% |
Dec 31, 2010 | 3.92B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cencora | 271.58B |
Centene | 154.00B |
Takeda Pharmaceutical | 29.40B |
Becton, Dickinson and Company | 19.49B |
Zoetis | 8.54B |
Moderna | 6.85B |
Agilent Technologies | 6.74B |
Edwards Lifesciences | 6.00B |
IQV News
- 4 days ago - IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards - Business Wire
- 11 days ago - IQVIA to Announce First-Quarter 2024 Results on May 2, 2024 - Business Wire
- 18 days ago - IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud - Business Wire
- 7 weeks ago - IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024 - Business Wire
- 2 months ago - IQVIA Publishes its 2023 Environmental, Social and Governance Report - Business Wire
- 2 months ago - IQVIA CFO Ron Bruehlman to Speak at Citi's Unplugged Medtech and Life Sciences Access Day on February 29, 2024 - Business Wire
- 2 months ago - IQVIA quarterly results beat estimates on strong demand for research services - Reuters
- 2 months ago - IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance - Business Wire